NCT06518070

Results Comparison of Cervical Cancer Early Detection Using Cerviray With VIA Test

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 44 (actual)
• Sponsor: Universitas Padjadjaran · Academic / Other
• Sex: Female
• Age: —
• Healthy volunteers: Accepted

Summary

Cervical cancer, primarily caused by Human Papilloma Virus (HPV), is a significant global health concern, ranking as the fourth most common cancer in women worldwide. In Indonesia, it stands as the second most frequent cancer among women. This study investigates the performance of Cerviray® AI and Cerviray® AI Evaluation, an artificial intelligence (AI) technology for diagnosing cervical cancer, aiming to compare its sensitivity, specificity, positive predictive value (PPV), and area under the receiver operating characteristic curve (AUC ROC) with the Visual Inspection with Acetic Acid (VIA) test.

Detailed description

The study involved 44 patients from various health centers in West Java Province. Cerviray® AI, Cerviray® AI Evaluation, and VIA tests were administered to high-risk women of childbearing age.

Conditions

• Cervical Cancer

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Cerviray AI	Patient was screened using Cerviray AI, Cerviray AI evaluation by expert anc compared to VIA test in the same day.

Timeline

• Start date: 2023-03-01
• Primary completion: 2023-10-31
• Completion: 2023-10-31
• First posted: 2024-07-24
• Last updated: 2024-07-24

Locations

1 site across 1 country: Indonesia